Yunzhi Chen
Biographic Data
| ID | 7261773 |
|---|---|
| NAME | Yunzhi Chen |
| GIVEN NAMES | Yunzhi |
| FAMILY NAME | Chen |
| SIGNATURE | CHEN Y |
| AFFILIATIONS | Guiyang Medical University |
| ORCID | 0000-0002-4546-5341 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Rocaglamide reprograms glucose metabolism in erythroleukemic cells via c-MYC transcriptional regulation of TXNIP and HK2
QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-Abca1 pathway
The anti-atherosclerotic mechanism of QSYQ was involved in inhibiting lipid phagocytosis and promoting reverse cholesterol transport, therefore reducing lipid deposition and inflammatory cells in plaque.
No prominent works on this page.
QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-Abca1 pathway
The anti-atherosclerotic mechanism of QSYQ was involved in inhibiting lipid phagocytosis and promoting reverse cholesterol transport, therefore reducing lipid deposition and inflammatory cells in plaque.
Rocaglamide reprograms glucose metabolism in erythroleukemic cells via c-MYC transcriptional regulation of TXNIP and HK2
Biology (2 works) · Gene (2 works) · ABCA1 (1 work) · Aorta (1 work) · Aspirin (1 work) · Biochemistry (1 work) · Biochemistry (1 work) · Cancer Research (1 work) · Cancer, Lipids, and Metabolism (1 work) · Carbohydrate Metabolism (1 work)